General Insurance Corporation of India (GICRE)
🎯 Key Takeaways
- GICRE is in a strategic transition phase focused on improving underwriting profitability and portfolio quality rather than pursuing growth. Management is actively rebalancing its reinsurance portfolio toward non-property and retail health segments, targeting combined ratios of 103 (domestic) and 95 (foreign) within 2-3 years, while maintaining a long-term 60/40 domestic-international mix.
- ⚠️ Overreliance on investment income to offset underwriting volatility, as net worth remains flat despite profitability due to market value fluctuations
📖 The Story
GICRE is in a strategic transition phase focused on improving underwriting profitability and portfolio quality rather than pursuing growth. Management is actively rebalancing its reinsurance portfolio toward non-property and retail health segments, targeting combined ratios of 103 (domestic) and 95 (foreign) within 2-3 years, while maintaining a long-term 60/40 domestic-international mix. Despite flat net worth due to market volatility, the company is prioritizing solvency strength and underwriting discipline, as evidenced by improvements in claim ratio and solvency metrics.
📰 What's Happening
In Q1 FY27, GICRE reported a 13.6% YoY increase in gross premium income to ₹13,475.36 crores, driven by domestic growth and improved underwriting with claim ratio declining to 85.04% from 90.42%. Profit after tax rose to ₹1,922.04 crores, and solvency ratio strengthened to 4.32 from 3.85 YoY. The company revised its investor presentation to correct typographical errors in claim ratio and net-worth figures, but no material changes to financial outlook. The Board recommended a dividend of ₹13.25 per share for FY 2025-26, pending shareholder approval at the AGM, with TDS rules updated under the new Income Tax Act, 2025, requiring documentation by September 7 to avoid 20% withholding.
Source: Stock Announcements
📊 Quarterly Results (₹ Cr)
| Metric | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | — |
| Operating Profit | — | — | — | — | — |
| OPM % | — | — | — | — | — |
| Net Profit | — | — | — | — | — |
| EPS | — | — | — | — | — |
The company has demonstrated consistent underwriting improvement, with claim ratio declining and combined ratio improving to 104.88% in Q1 FY27 from prior periods, while premium growth remained robust at 8.8-13.6% YoY. Profitability increased to ₹1,922.04 crores in Q1 FY27, supported by investment income and lower claims, though flat net worth reflects market value volatility in the investment portfolio. These trends align with management’s stated focus on underwriting discipline and portfolio rebalancing rather than revenue expansion.
🔮 Management Outlook & What's Next
Management has explicitly targeted combined ratios of 103 (domestic) and 95 (foreign) within 2-3 years, aiming for a long-term 60/40 domestic-international portfolio mix and ~10% growth with higher foreign growth expectations. They emphasize maintaining capital resilience while expanding internationally, leveraging the credit rating upgrade to support geographic diversification and enhanced risk modeling capabilities.
Extracted from official company announcements. Not StockFin.ai's opinion.
🏦 Balance Sheet (₹ Cr)
| Item | Mar 2025 | Mar 2026 | Mar 2026 | Mar 2026 | Mar 2027 |
|---|---|---|---|---|---|
| Equity Capital | 877 | 877 | 877 | 877 | 877 |
| Reserves | 47,782 | 66,730 | 69,714 | 69,604 | 73,241 |
| Borrowings | 0 | 0 | 1 | 0 | 1 |
| Total Liabilities | — | 95,801 | 2.11 L Cr | 2.06 L Cr | 2.18 L Cr |
| Fixed Assets | 327 | 302 | 298 | 304 | 303 |
| Investments | — | 1.51 L Cr | 1.55 L Cr | 1.48 L Cr | 1.55 L Cr |
| Total Assets | — | 95,801 | 2.11 L Cr | 2.06 L Cr | 2.18 L Cr |
The balance sheet shows stable equity of ₹877 crores with reserves growing from ₹69,604 to ₹73,241 crores over the past year, indicating retained earnings despite flat total assets at ₹2.18 L Cr in March 2027. Borrowings remain minimal at ₹1 crore, reflecting a conservative capital structure. The company maintains strong liquidity and capital adequacy, with solvency ratio at 4.32, supporting its strategic focus on underwriting profitability and long-term stability without aggressive leverage or capital return beyond dividends.
💰 Cash Flow Statement (₹ Cr)
| Item | Mar 2025 |
|---|---|
| Operating | +1,976 |
| Investing | -926 |
| Financing | -1,754 |
| Net Cash Flow | -53 |
👥 Shareholding Pattern
| Category | Q2FY26 | Q3FY26 | Q4FY26 | Q1FY27 |
|---|---|---|---|---|
| Promoters | 82.4% | 82.4% | 82.4% | 77.4% |
| FII | 2.1% | 2.1% | 2.1% | 2.4% |
| DII | 13.1% | 13.3% | 13.6% | 17.7% |
| Public | 1.9% | 1.7% | 1.5% | 1.9% |
| # Shareholders | 2,30,683 | 2,24,559 | 2,17,494 | 2,24,351 |
Promoter holding has declined slightly from 82.4% to 77.4% in Q1FY27, while FII and DII holdings have increased from 2.06% to 2.43% and 13.55% to 17.73% respectively, suggesting growing institutional confidence. The number of public shareholders has also risen to 2,24,351, indicating broader retail participation. No pledging or significant dilution is evident, and the stable promoter stake with rising institutional interest supports a positive governance signal.
⚖️ Peer Comparison — Insurance
| Company | MCap (₹ Cr) | P/E | ROCE | ROE | D/E |
|---|---|---|---|---|---|
| LICI | 5.28 L Cr | — | — | — | 0.00 |
| SBILIFE | 1.75 L Cr | — | — | — | 0.00 |
| HDFCLIFE | 1.18 L Cr | — | — | — | 0.00 |
| ICICIGI | 77,881 | — | — | — | 0.00 |
| ICICIPRULI | 74,135 | — | — | — | 0.00 |
| GICRE | 62,246 | — | — | — | 0.00 |
| STARHEALTH | 33,419 | — | — | — | 0.00 |
| NIACL | 31,543 | — | — | — | 0.00 |
| GODIGIT | 23,878 | — | — | — | 0.00 |
| NIVABUPA | 15,023 | — | — | — | 0.00 |
🔗 Peer Stock Analyses
⚠️ Risk Factors
1. Overreliance on investment income to offset underwriting volatility, as net worth remains flat despite profitability due to market value fluctuations in the investment portfolio. 2. International expansion carries execution and geopolitical risks, particularly in South Africa and Moscow, where subsidiary losses were observed in prior periods. 3. Regulatory and tax changes, such as the new TDS provisions under the Income Tax Act, 2025, could impact shareholder returns if documentation deadlines are missed. 4. Market volatility in premium and investment values may continue to pressure near-term net worth, despite improving operational metrics.
📋 Recent Filings
-
🔴 annual report 31 August 2026The filing is an annual report under SEBI Regulation 34(1) for General Insurance Corporation of India (GICRE) dated 31 August 2026, covering FY 2025-2...
-
🟡 Board Meeting 31 August 2026GICRE announced its 54th AGM on 22 September 2026, seeking shareholder approval for key director appointments including Hitesh Joshi as CMD and Dr. Pr...
-
🟡 sustainability report 31 August 2026The filing confirms GICRE's BRSR report for FY 2025-26, covering ESG disclosures across 9 principles. It details governance structures, employee welfa...
-
🔴 Financial Results 20 August 2026GIC reported gross premium income of **₹13,475.36 crores** in Q1 FY27, up 13.6% YoY, driven by improved underwriting with claim ratio declining to 85....
-
🔴 Financial Results 19 August 2026GIC Re revised its Q1 FY27 investor presentation to correct typographical errors in claim ratio and net-worth figures, while confirming no material ch...
-
Announcement 17 August 2026GICRE held an earnings call on August 17, 2026, to discuss unaudited standalone and consolidated financial results for the quarter ended June 30, 2026...
-
🟡 Board Meeting 15 August 2026The Board recommended a dividend of Rs. 13.25 per share for FY 2025-26, subject to shareholder approval at the upcoming AGM, with a record date of Sep...
-
🔴 Financial Results 15 August 2026GIC Re reported a 69.9% YoY increase in gross written premium to ₹44,007 crores for Q1 FY26-27, driven by strong reinsurance demand and market expansi...
-
🟡 Board Meeting 13 August 2026GIC Re reported strong Q1 FY27 results with Gross Premium Income rising 8.8% YoY to ₹13,475.36 crore, driven by domestic growth (+12.3%) and improved ...
-
🟡 Board Meeting 13 August 2026The Ministry of Finance appointed Hiteshkumar Kismatbhai Bhandari as a Part-time Non-Official Director on the Board of General Insurance Corporation o...
🧠 Analyst's Read
GICRE is executing a disciplined transformation focused on underwriting quality and portfolio optimization, with improving operational metrics and strategic international ambitions. Investors should monitor progress toward combined ratio targets and the pace of international growth, as well as how effectively the company navigates market volatility in its investment portfolio, which currently constrains net worth despite strong profitability.
Based on filing content and financial data. Not a recommendation.
Read the full analysis
Quarterly trends, balance sheet, cash flow, peer comparison, and AI insights — sign up free to unlock.
Sign Up Free — Unlock Full Analysis2 free AI queries per day.
Data sourced from stock announcements. Analysis generated by StockFin.ai.
For informational purposes only — not investment advice. Updated 2026-09-02.
Editorial & Data Transparency Notice
This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.
📡 Get AI alerts when GICRE files new disclosures
Track GICRE filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track GICRE — FreeFree account · 2 AI queries/day
© 2026 StockFin.ai — AI-powered Indian stock research
About · Privacy Policy · Terms of Service · Pricing
Today's Announcements · Screener · Insights · AI Chat
Data provided by CMOTS Internet Technologies Pvt Ltd